Search research articles
Contact Us
Filters
Showing results (21-30 of 84) with videos related to
Page
of 9
Sort By:
Kidney International
|
April 1, 1996
Interleukin-1 beta up-regulates the plasminogen activator/plasmin system in human mesangial cells
H M Wilson, N E Haites, F J Reid, et al.
Lancet (London, England)
|
April 6, 1996
Cystic fibrosis screening policies
M H Hall, Z H Miedzybrodzka, N E Haites, et al.
Biochemical and Biophysical Research Communications
|
March 15, 1994
Regulation of alternative splicing of the fibronectin IIICS domain by cytokines
N G McKay, D J Hunter, N E Haites, et al.
Experimental and Molecular Pathology
|
December 1, 1993
The effect of transforming growth factor beta 1 on mesangial cell fibronectin synthesis: increased incorporation into the extracellular matrix and reduced pI but no effect on alternative splicing
N G McKay, T F Khong, N E Haites, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 1, 1996
Polymorphisms in P21CIP1/WAF1 are not correlated with TP53 status in sporadic ovarian tumours
B J Milner, L Hosking, S Sun, et al.
The British Journal of Ophthalmology
|
December 1, 1994
Rhodopsin mutations in a Scottish retinitis pigmentosa population, including a novel splice site mutation in intron four
C Bell, C A Converse, H M Hammer, et al.
Journal of Human Hypertension
|
April 24, 2001
Is random screening of value in detecting glucocorticoid-remediable aldosteronism within a hypertensive population?
L J Gates, N Benjamin, N E Haites, et al.
British Journal of Haematology
|
January 1, 1995
p53 mutation in the myelodysplastic syndromes
D J Adamson, A A Dawson, B Bennett, et al.
Human Mutation
|
February 6, 1998
Rhodopsin splice site sequence changes in retinitis pigmentosa and their effect at the mRNA level
J L Whitehead, C Bell, C A Converse, et al.
British Journal of Cancer
|
July 1, 1995
p53 mutation and expression in lymphoma
D J Adamson, W D Thompson, A A Dawson, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 84) with videos related to
Sort By:
Page
of 9
Kidney International
|
April 1, 1996
Interleukin-1 beta up-regulates the plasminogen activator/plasmin system in human mesangial cells
H M Wilson, N E Haites, F J Reid, et al.
Lancet (London, England)
|
April 6, 1996
Cystic fibrosis screening policies
M H Hall, Z H Miedzybrodzka, N E Haites, et al.
Biochemical and Biophysical Research Communications
|
March 15, 1994
Regulation of alternative splicing of the fibronectin IIICS domain by cytokines
N G McKay, D J Hunter, N E Haites, et al.
Experimental and Molecular Pathology
|
December 1, 1993
The effect of transforming growth factor beta 1 on mesangial cell fibronectin synthesis: increased incorporation into the extracellular matrix and reduced pI but no effect on alternative splicing
N G McKay, T F Khong, N E Haites, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 1, 1996
Polymorphisms in P21CIP1/WAF1 are not correlated with TP53 status in sporadic ovarian tumours
B J Milner, L Hosking, S Sun, et al.
The British Journal of Ophthalmology
|
December 1, 1994
Rhodopsin mutations in a Scottish retinitis pigmentosa population, including a novel splice site mutation in intron four
C Bell, C A Converse, H M Hammer, et al.
Journal of Human Hypertension
|
April 24, 2001
Is random screening of value in detecting glucocorticoid-remediable aldosteronism within a hypertensive population?
L J Gates, N Benjamin, N E Haites, et al.
British Journal of Haematology
|
January 1, 1995
p53 mutation in the myelodysplastic syndromes
D J Adamson, A A Dawson, B Bennett, et al.
Human Mutation
|
February 6, 1998
Rhodopsin splice site sequence changes in retinitis pigmentosa and their effect at the mRNA level
J L Whitehead, C Bell, C A Converse, et al.
British Journal of Cancer
|
July 1, 1995
p53 mutation and expression in lymphoma
D J Adamson, W D Thompson, A A Dawson, et al.
Page
of 9